Neuroprotection in Parkinsonian-treated mice via estrogen receptor α activation requires G protein-coupled estrogen receptor 1

Neuropharmacology

Volumn 95, Issue , 2015, Pages 343-352

  Bourque, Mélanie ^a,b   Morissette, Marc ^a   Di Paolo, Thérèse ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

17 Estradiol; Akt; Estrogen receptor; GPER1; MPTP; Neuroprotection

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; 3BETA ANDROSTANEDIOL; ANDROGEN; ANDROSTANOLONE; BRAIN DERIVED NEUROTROPHIC FACTOR; DIARYLPROPIONITRILE; DOPAMINE; DOPAMINE TRANSPORTER; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ANTAGONIST; ESTROGEN RECEPTOR BETA; FULVESTRANT; G PROTEIN COUPLED RECEPTOR 30; G PROTEIN COUPLED RECEPTOR 30 AGONIST G1; G PROTEIN COUPLED RECEPTOR 30 ANTAGONIST G15; GLYCOGEN SYNTHASE KINASE 3BETA; HORMONE RECEPTOR AFFECTING AGENT; PROGESTERONE; PROTEIN BCL 2; STEROID; TESTOSTERONE; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2; ANTIPARKINSON AGENT; ESTROGEN; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GPR30 PROTEIN, MOUSE; NEUROPROTECTIVE AGENT;

ANDROGEN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG EFFECT; ENZYME ACTIVITY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STEROID BLOOD LEVEL; SUBSTANTIA NIGRA; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; C57BL MOUSE; DRUG EFFECTS; METABOLISM; PARKINSONIAN DISORDERS;

ANIMALS; ANTIPARKINSON AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORPUS STRIATUM; DOPAMINE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ANTAGONISTS; ESTROGEN RECEPTOR BETA; ESTROGENS; MALE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; PARKINSONIAN DISORDERS; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; STEROIDS;

EID: 84928527130     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2015.04.006     Document Type: Article

References (51)

1. S. Al-Sweidi, M. Morissette, M. Bourque, and T. Di Paolo Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease Neuropharmacology 61 2011 583 591
2. E. Audet-Walsh, J. Lepine, J. Gregoire, M. Plante, P. Caron, B. Tetu, P. Ayotte, J. Brisson, L. Villeneuve, A. Belanger, and C. Guillemette Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics J. Clin. Endocrinol. Metab. 96 2011 E330 E339
3. A.M. Baraka, A.A. Korish, G.A. Soliman, and H. Kamal The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson's disease Life Sci. 88 2011 879 885
4. C.G. Bologa, C.M. Revankar, S.M. Young, B.S. Edwards, J.B. Arterburn, A.S. Kiselyov, M.A. Parker, S.E. Tkachenko, N.P. Savchuck, L.A. Sklar, T.I. Oprea, and E.R. Prossnitz Virtual and biomolecular screening converge on a selective agonist for GPR30 Nat. Chem. Biol. 2 2006 207 212
5. M. Bourque, D.E. Dluzen, and T. Di Paolo Neuroprotective actions of sex steroids in Parkinson's disease Front. Neuroendocrinol. 30 2009 142 157
6. M. Bourque, M. Morissette, M. Cote, D. Soulet, and T. Di Paolo Implication of GPER1 in neuroprotection in a mouse model of Parkinson's disease Neurobiol. Aging 34 2013 887 901
7. M. Bourque, M. Morissette, and T. Di Paolo Raloxifene activates G protein-coupled estrogen receptor 1/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice Neurobiol. Aging 35 2014 2347 2356
8. S. Callier, M. Morissette, M. Grandbois, D. Pelaprat, and T. Di Paolo Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice Synapse 41 2001 131 138
9. M. D'Astous, P. Mendez, M. Morissette, L.M. Garcia-Segura, and T. Di Paolo Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice Mol. Pharmacol. 69 2006 1492 1498
10. M. D'Astous, M. Morissette, and T. Di Paolo Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist Neuropharmacology 47 2004 1180 1188
11. M.K. Dennis, A.S. Field, R. Burai, C. Ramesh, W.K. Petrie, C.G. Bologa, T.I. Oprea, Y. Yamaguchi, S. Hayashi, L.A. Sklar, H.J. Hathaway, J.B. Arterburn, and E.R. Prossnitz Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity J. Steroid Biochem. Mol. Biol. 127 2011 358 366
12. K. Franklin, and G. Paxinos The Mouse Brain in Stereotaxic Coordinates 1997 Academic Press San Diego
13. F. Gao, X. Ma, A.B. Ostmann, and S.K. Das GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERalpha) phosphorylation signals Endocrinology 152 2011 1434 1447
14. G.E. Gillies, I.S. Pienaar, S. Vohra, and Z. Qamhawi Sex differences in Parkinson's disease Front. Neuroendocrinol. 35 2014 370 384
15. S. Gingerich, G.L. Kim, J.A. Chalmers, M.M. Koletar, X. Wang, Y. Wang, and D.D. Belsham Estrogen receptor alpha and G-protein coupled receptor 30 mediate the neuroprotective effects of 17beta-estradiol in novel murine hippocampal cell models Neuroscience 170 2010 54 66
16. J. Gonzalez-Maeso GPCR oligomers in pharmacology and signaling Mol. Brain 4 2011 20
17. M.L. Gould, P.R. Hurst, and H.D. Nicholson The effects of oestrogen receptors alpha and beta on testicular cell number and steroidogenesis in mice Reproduction 134 2007 271 279
18. T. Kenakin, and A. Christopoulos Signalling bias in new drug discovery: detection, quantification and therapeutic impact Nat. Rev. Drug Discov. 12 2013 205 216
19. M. Kilbourn, and K. Frey Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL/6) and -insensitive (CD-1) mouse strains Eur. J. Pharmacol. 307 1996 227 232
20. P. Kumar, Q. Wu, K.L. Chambliss, I.S. Yuhanna, S.M. Mumby, C. Mineo, G.G. Tall, and P.W. Shaul Direct Interactions with G alpha i and G betagamma mediate nongenomic signaling by estrogen receptor alpha Mol. Endocrinol. 21 2007 1370 1380
21. J. Kuo, N. Hamid, G. Bondar, E.R. Prossnitz, and P. Micevych Membrane estrogen receptors stimulate intracellular calcium release and progesterone synthesis in hypothalamic astrocytes J. Neurosci. 30 2010 12950 12957
22. M.R. Lamprecht, and B. Morrison 3rd GPR30 activation is neither necessary nor sufficient for acute neuroprotection by 17beta-estradiol after an ischemic injury in organotypic hippocampal slice cultures Brain Res. 1563 2014 131 137
23. R. Lappano, P. De Marco, E.M. De Francesco, A. Chimento, V. Pezzi, and M. Maggiolini Cross-talk between GPER and growth factor signaling J. Steroid Biochem. Mol. Biol. 137 2013 50 56
24. S.B. Liu, J. Han, N. Zhang, Z. Tian, X.B. Li, and M.G. Zhao Neuroprotective effects of oestrogen against oxidative toxicity through activation of G-protein-coupled receptor 30 receptor Clin. Exp. Pharmacol. Physiol. 38 2011 577 585
25. K. Maeda, S. Ohkura, Y. Uenoyama, Y. Wakabayashi, Y. Oka, H. Tsukamura, and H. Okamura Neurobiological mechanisms underlying GnRH pulse generation by the hypothalamus Brain Res. 1364 2010 103 115
26. M. Marino, P. Galluzzo, and P. Ascenzi Estrogen signaling multiple pathways to impact gene transcription Curr. Genomics 7 2006 497 508
27. P. Mendez, F. Wandosell, and L.M. Garcia-Segura Cross-talk between estrogen receptors and insulin-like growth factor-I receptor in the brain: cellular and molecular mechanisms Front. Neuroendocrinol. 27 2006 391 403
28. M.J. Meyers, J. Sun, K.E. Carlson, G.A. Marriner, B.S. Katzenellenbogen, and J.A. Katzenellenbogen Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues J. Med. Chem. 44 2001 4230 4251
29. M. Morissette, S. Jourdain, S. Al Sweidi, F.S. Menniti, A.D. Ramirez, and T. Di Paolo Role of estrogen receptors in neuroprotection by estradiol against MPTP toxicity Neuropharmacology 52 2007 1509 1520
30. G. Notas, M. Kampa, V. Pelekanou, and E. Castanas Interplay of estrogen receptors and GPR30 for the regulation of early membrane initiated transcriptional effects: a pharmacological approach Steroids 77 2012 943 950
31. K. Nozu, M.L. Dufau, and K.J. Catt Estradiol receptor-mediated regulation of steroidogenesis in gonadotropin-desensitized Leydig cells J. Biol. Chem. 256 1981 1915 1922
32. A. Parcellier, L.A. Tintignac, E. Zhuravleva, and B.A. Hemmings PKB and the mitochondria: Akting on apoptosis Cell. Signal 20 2008 21 30
33. W.K. Petrie, M.K. Dennis, C. Hu, D. Dai, J.B. Arterburn, H.O. Smith, H.J. Hathaway, and E.R. Prossnitz G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth Obstet. Gynecol. Int. 2013 2013 472720
34. A. Quesada, B.Y. Lee, and P.E. Micevych PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease Dev. Neurobiol. 68 2008 632 644
35. A. Quesada, and P.E. Micevych Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions J. Neurosci. Res. 75 2004 107 116
36. L. Raz, M.M. Khan, V.B. Mahesh, R.K. Vadlamudi, and D.W. Brann Rapid estrogen signaling in the brain Neurosignals 16 2008 140 153
37. C.M. Revankar, D.F. Cimino, L.A. Sklar, J.B. Arterburn, and E.R. Prossnitz A transmembrane intracellular estrogen receptor mediates rapid cell signaling Science 307 2005 1625 1630
38. R. Ruffoli, M.A. Giambelluca, M.C. Scavuzzo, L. Pasquali, F. Giannessi, and F. Fornai MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss Brain Res. 1229 2008 218 223
39. I. Ruiz-Palmero, M. Hernando, L.M. Garcia-Segura, and M.A. Arevalo G protein-coupled estrogen receptor is required for the neuritogenic mechanism of 17beta-estradiol in developing hippocampal neurons Mol. Cell. Endocrinol. 372 2013 105 115
40. I. Ruiz-Palmero, J. Simon-Areces, L.M. Garcia-Segura, and M.A. Arevalo Notch/neurogenin 3 signalling is involved in the neuritogenic actions of oestradiol in developing hippocampal neurones J. Neuroendocrinol. 23 2011 355 364
41. M.G. Sanchez, M. Bourque, M. Morissette, and T. Di Paolo Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders CNS Neurosci. Ther. 16 2010 e43 71
42. F. Sohrabji, R.C. Miranda, and C.D. Toran-Allerand Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor Proc. Natl. Acad. Sci. U. S. A. 92 1995 11110 11114
43. S.R. Stauffer, C.J. Coletta, R. Tedesco, G. Nishiguchi, K. Carlson, J. Sun, B.S. Katzenellenbogen, and J.A. Katzenellenbogen Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists J. Med. Chem. 43 2000 4934 4947
44. H. Tang, Q. Zhang, L. Yang, Y. Dong, M. Khan, F. Yang, D.W. Brann, and R. Wang GPR30 mediates estrogen rapid signaling and neuroprotection Mol. Cell. Endocrinol. 387 2014 52 58
45. P. Thomas, Y. Pang, E.J. Filardo, and J. Dong Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells Endocrinology 146 2005 624 632
46. L. Vaucher, M.G. Funaro, A. Mehta, A. Mielnik, A. Bolyakov, E.R. Prossnitz, P.N. Schlegel, and D.A. Paduch Activation of GPER-1 estradiol receptor downregulates production of testosterone in isolated rat Leydig Cells and adult human testis PLoS One 9 2014 e92425
47. A. Vivacqua, R. Lappano, P. De Marco, D. Sisci, S. Aquila, F. De Amicis, S.A. Fuqua, S. Ando, and M. Maggiolini G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells Mol. Endocrinol. 23 2009 1815 1826
48. A.E. Wakeling, M. Dukes, and J. Bowler A potent specific pure antiestrogen with clinical potential Cancer Res. 51 1991 3867 3873
49. S. Wang, P. Ren, X. Li, Y. Guan, and Y.A. Zhang 17beta-Estradiol protects dopaminergic neurons in organotypic slice of mesencephalon by MAPK-mediated activation of anti-apoptosis gene BCL2 J. Mol. Neurosci. 45 2011 236 245
50. L.C. Yang, Q.G. Zhang, C.F. Zhou, F. Yang, Y.D. Zhang, R.M. Wang, and D.W. Brann Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus PLoS One 5 2010 e9851
51. Q.G. Zhang, L. Raz, R. Wang, D. Han, L. De Sevilla, F. Yang, R.K. Vadlamudi, and D.W. Brann Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation J. Neurosci. 29 2009 13823 13836